6 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer TreatmentCongenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, injury, radiation injury, radiation-induced disorderRecruitingNot stated2026-09-25NCT06816095
Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).Hypesthesia, Neurologic Manifestations, Paresthesia, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Somatosensory Disorders, anxiety disorder, depressive disorder, nervous system disorder, psychiatric disorderRecruitingPhase 2 / Phase 32026-09-25NCT06799351
Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025Chronic Pain, Intractable Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, anxiety disorder, depressive disorder, injury, psychiatric disorder, radiation injuryActive, not recruitingNot stated2026-09-25NCT05417737
Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder, psychiatric disorder, somatoform disorderRecruitingPhase 2 / Phase 32026-09-25NCT04299893
Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029.Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, anxiety disorder, depressive disorder, injury, psychiatric disorder, radiation injuryRecruitingNot stated2026-09-23NCT07325851
Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral NeuropathyHypesthesia, Neurologic Manifestations, Paresthesia, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Somatosensory Disorders, anxiety disorder, depressive disorder, nervous system disorder, psychiatric disorderRecruitingPhase 2 / Phase 32026-09-18NCT06706544